Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A prospective non-interventional single-centre study aimed to assess the current practice of non-pharmacological treatment and pharmacological therapy of overweight and obesity in patients with cardiovascular diseases (CVD) or with a high risk of CVD according to the patients' survey data
To interview 300 patients with a body mass index (BMI) ≥25 kg / m² of the outpatient register, who come for a primary or secondary visit to the Center. The specifically designed questionnaire contains topics about patients' self-concept of their body mass; doctors' prescriptions of therapy for obesity, patients' adherence to recommendations.
A repeated short telephone interview of these patients will be conducted in 1-1.5 years after visit inclusion to clarify the dynamics of weight and methods of its correction.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The proportion of patients received non-pharmacological treatment recommendations | Non-pharmacological methods of treatment: diet treatment, increasing physical activity | on enrollment |
| The proportion of patients received pharmacological treatment recommendations | Anti-obesity drug treatment prescribing | on enrollment |
| Patients' self-concept of their body mass | The proportion of patients who assess their weight as normal weight, overweight or obesity. Patient knowledge of obesity and overweight treatment methods | on enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Effect of overweight and obesity treatment | Dynamics of the patient's body weight in a prospective observation | April, 2019 - November, 2020 |
| Patient self-assessment of previous overweight and obesity treatments effectiveness |
Not provided
Inclusion Criteria:
patients of the outpatient "PROFILE" registry with CVD or with a high risk of CVD (≥5%), with overweight (BMI≥25 kg/m2) or obesity (BMI≥30 kg/m2). Presence of written informed consent to participate in the study, fill in the original questionnaire and given consent to the processing of personal data
Exclusion Criteria:
normal weight, pregnancy
Not provided
Not provided
Not provided
patients with overweight or obesity and with CVD or with a high risk of CVD
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sergey Yu Martsevich, MD, PhD | National Research Center for Preventive Medicine, Moscow, Russia, 101990 | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yulia Lukina | Moscow | 101990 | Russia |
Not provided
| ID | Term |
|---|---|
| D050177 | Overweight |
| D009765 | Obesity |
| ID | Term |
|---|---|
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
Not provided
Not provided
Not provided
Not provided
Not provided
The proportion of patients who rated the effectiveness of treatment as effective short-term, effective long-term, ineffective
| April, 2019 - November, 2020 |
| D012816 |
| Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |